Hematology-Oncology
Hematologic Response to Iron Therapy and Stillbirth Risk in Moderate Iron Deficiency Anemia
Study reveals inadequate hemoglobin improvement at 20-24 weeks after iron therapy increases stillbirth and preterm birth risks in moderate iron deficiency anemia pregnancies, highlighting need for early intervention.
